ARS Pharmaceuticals Inc

SPRY

Company Profile

  • Business description

    ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

  • Contact

    11682 El Camino Real
    Suite 120
    San DiegoCA92130
    USA

    T: +1 858 771-9307

    https://www.ars-pharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    160

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,743.6030.00-0.34%
CAC 407,691.55134.241.78%
DAX 4024,033.22383.921.62%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.9163.310.72%
HKSE24,284.1541.25-0.17%
NASDAQ20,273.46105.550.52%
Nikkei 22540,150.79566.211.43%
NZX 50 Index12,583.59103.540.83%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,514.2036.60-0.43%
SSE Composite Index3,424.2324.23-0.70%

Market Movers